Aerovate Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy AVTE

*Your capital is at risk

$2.68

+0 (+0%)

At Close: Jul 25, 2025

Currently predicting for Thu, 6 Aug 2026

AVTE Live board

Community Bull/Bear

Target Next close

Join the AVTE prediction battle

Create a free account to see the full board, submit your call, compare with other predictors, and build a public record.

Create free account Log in

AVTE Prediction Chart

Unlock the prediction chart

Registered users can inspect target prices, community averages, and how calls develop across recent sessions.

Create free account Log in

Forecast Desk

3-Month Forecasts For AVTE

Forecasts map a 66-session price path from approved predictors. Log in or create a free account to view forecasts and request one for this ticker.

Create free account Log in to view forecasts

AVTE Predictions History

Predictor	Target Session	Target Price	Accuracy
Community predictor	Next session	USD target	Record locked
Ranked predictor	Previous session	Bullish/Bearish	Score locked

See the prediction record

Create free account Log in

Forecast Desk

Request A 3-Month Forecast

Price path
Approved predictor
3-month horizon

Create Free Account Log In To View Forecasts

ABOUT AEROVATE THERAPEUTICS, INC.

Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. Aerovate Therapeutics, Inc. was incorporated in 2018 and is headquartered...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
FCX $62.63	7.46%	Jul 31
MC $67.08	2.40%	Jul 31
ARW $212.85	6.96%	Jul 30
BIIB $202.19	3.10%	Jul 24
F FERG $230.67	10.77%	Jul 24

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by